Teva Pharmaceutical (Israel) Price History

TEVA Stock  ILA 6,041  42.00  0.70%   
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. As of today, the current price of Teva Pharmaceutical stands at 6,041, as last reported on the 28th of November, with the highest price reaching 6,071 and the lowest price hitting 5,992 during the day. Teva Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17% return per unit of risk over the last 3 months. Teva Pharmaceutical Industries exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Teva Pharmaceutical's Semi Deviation of 1.86, coefficient of variation of 18271.41, and Risk Adjusted Performance of 0.0101 to confirm the risk estimate we provide.
  
Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1685

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTEVA

Estimated Market Risk

 1.62
  actual daily
14
86% of assets are more volatile

Expected Return

 -0.27
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.17
  actual daily
0
Most of other assets perform better
Based on monthly moving average Teva Pharmaceutical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharmaceutical by adding Teva Pharmaceutical to a well-diversified portfolio.

Teva Pharmaceutical Stock Price History Chart

There are several ways to analyze Teva Stock price data. The simplest method is using a basic Teva candlestick price chart, which shows Teva Pharmaceutical price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 4, 20246982.0
Lowest PriceNovember 26, 20245999.0

Teva Pharmaceutical November 28, 2024 Stock Price Synopsis

Various analyses of Teva Pharmaceutical's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Teva Stock. It can be used to describe the percentage change in the price of Teva Pharmaceutical from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Teva Stock.
Teva Pharmaceutical Price Action Indicator 30.50 
Teva Pharmaceutical Price Daily Balance Of Power 0.53 
Teva Pharmaceutical Price Rate Of Daily Change 1.01 

Teva Pharmaceutical November 28, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Teva Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Teva Pharmaceutical intraday prices and daily technical indicators to check the level of noise trading in Teva Stock and then apply it to test your longer-term investment strategies against Teva.

Teva Stock Price History Data

The price series of Teva Pharmaceutical for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 983.0 with a coefficient of variation of 3.82. The price distribution for the period has arithmetic mean of 6592.5. The median price for the last 90 days is 6635.0. The company completed stock split (2:1) on 27th of June 2004. Teva Pharmaceutical had dividends distributed to its stock-holders on 2017-11-28.
OpenHighLowCloseVolume
11/28/2024
 6,001  6,071  5,992  6,041 
11/27/2024 6,001  6,071  5,992  6,041  1,208,159 
11/26/2024 6,047  6,061  5,957  5,999  2,153,068 
11/25/2024 6,330  6,355  6,054  6,135  3,284,105 
11/21/2024 6,335  6,380  6,297  6,340  876,415 
11/20/2024 6,290  6,356  6,270  6,320  928,189 
11/19/2024 6,214  6,214  6,130  6,200  981,048 
11/18/2024 6,199  6,213  6,050  6,082  1,219,160 
11/14/2024 6,380  6,412  6,270  6,302  1,086,447 
11/13/2024 6,462  6,517  6,392  6,392  927,046 
11/12/2024 6,527  6,600  6,459  6,459  1,117,143 
11/11/2024 6,506  6,600  6,477  6,526  1,832,203 
11/07/2024 6,550  6,600  6,515  6,536  3,030,602 
11/06/2024 7,040  7,323  6,600  6,650  2,042,945 
11/05/2024 7,005  7,020  6,936  6,952  848,770 
11/04/2024 6,912  7,039  6,902  6,915  726,946 
10/31/2024 6,913  6,917  6,765  6,860  1,173,543 
10/30/2024 6,885  6,897  6,764  6,880  970,286 
10/29/2024 6,824  6,908  6,792  6,880  829,971 
10/28/2024 6,820  6,824  6,705  6,810  767,617 
10/22/2024 6,939  6,939  6,780  6,890  918,006 
10/21/2024 6,809  6,848  6,762  6,829  811,623 
10/15/2024 6,505  6,747  6,472  6,693  801,400 
10/14/2024 6,520  6,548  6,475  6,480  797,537 
10/10/2024 6,693  6,693  6,597  6,629  745,956 
10/09/2024 6,598  6,628  6,500  6,540  392,622 
10/08/2024 6,575  6,575  6,539  6,564  411,266 
10/07/2024 6,613  6,614  6,545  6,600  531,057 
10/01/2024 6,725  6,790  6,592  6,648  1,497,450 
09/30/2024 6,542  6,660  6,510  6,629  1,050,728 
09/26/2024 6,635  6,635  6,635  6,635  2,422,887 
09/25/2024 6,684  6,694  6,585  6,635  704,494 
09/24/2024 6,770  6,770  6,650  6,684  827,283 
09/23/2024 6,699  6,728  6,639  6,687  711,799 
09/19/2024 6,777  6,817  6,673  6,673  1,628,147 
09/18/2024 6,705  6,732  6,660  6,676  646,454 
09/17/2024 6,705  6,746  6,627  6,630  1,599,076 
09/16/2024 6,782  6,814  6,720  6,742  1,076,986 
09/12/2024 6,720  6,782  6,701  6,762  586,085 
09/11/2024 6,620  6,647  6,563  6,579  578,643 
09/10/2024 6,700  6,769  6,677  6,716  670,792 
09/09/2024 6,716  6,796  6,700  6,750  1,514,036 
09/05/2024 6,982  6,982  6,982  6,982  1,358,226 
09/04/2024 6,866  7,057  6,811  6,982  847,362 
09/03/2024 6,871  6,937  6,838  6,866  918,885 
09/02/2024 6,851  6,873  6,823  6,871  210,072 
08/29/2024 6,850  6,871  6,783  6,852  1,986,484 
08/28/2024 6,856  6,910  6,808  6,842  633,002 
08/27/2024 6,861  6,883  6,814  6,840  1,014,974 
08/26/2024 6,860  6,910  6,772  6,795  826,587 
08/22/2024 6,720  6,787  6,701  6,764  811,852 
08/21/2024 6,719  6,829  6,719  6,798  847,352 
08/20/2024 6,728  6,760  6,678  6,678  935,034 
08/19/2024 6,731  6,751  6,641  6,682  939,165 
08/15/2024 6,643  6,869  6,643  6,807  1,368,568 
08/14/2024 6,420  6,678  6,377  6,520  1,343,396 
08/12/2024 6,500  6,542  6,460  6,511  908,119 
08/08/2024 6,387  6,515  6,361  6,483  1,058,718 
08/07/2024 6,488  6,526  6,367  6,387  1,058,640 
08/06/2024 6,399  6,499  6,350  6,496  2,062,887 
08/05/2024 6,255  6,312  6,048  6,225  2,336,340 

About Teva Pharmaceutical Stock history

Teva Pharmaceutical investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharmaceutical will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharmaceutical stock prices may prove useful in developing a viable investing in Teva Pharmaceutical
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.

Teva Pharmaceutical Stock Technical Analysis

Teva Pharmaceutical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Teva Pharmaceutical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Teva Pharmaceutical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Balance Of Power Now

   

Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module

Teva Pharmaceutical Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Teva Pharmaceutical's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities